364328-07-4Relevant academic research and scientific papers
QUINAZOLINE COMPOUNDS
-
, (2015/06/11)
The present invention relates to quinazoline compounds of formula I that function as inhibitors of RET (rearranged during transfection) kinase enzyme activity: (Formula (I)) wherein X, R1, R2, R3, R4, R5, R6 and R7 are each as defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which RET kinase activity is implicated.
ANILINE DERIVATIVES,THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
-
Page/Page column 97, (2013/03/28)
The present invention relates to aniline derivatives, to their preparation and to their therapeutic application.
